with drugs like CDK4/6 inhibitor Ibrance (palbociclib), PARP inhibitor Talzenna (talazoparib), hormonal therapy Aromasin (exemestane) and trastuzumab biosimilar Trazimera. That range also opens up ...
In addition two heavily used oncology drugs: generic Imatinib and Rituximab ... Pfizer’s biosimilar of trastuzumab Trazimera, which treats breast cancer, will also significantly contribute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback